Influenza vaccine effectiveness against laboratory-confirmed influenza in hospitalised adults aged 60 years or older, Valencia Region, Spain, 2017/18 influenza season

scientific article published on 01 August 2019

Influenza vaccine effectiveness against laboratory-confirmed influenza in hospitalised adults aged 60 years or older, Valencia Region, Spain, 2017/18 influenza season is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2807/1560-7917.ES.2019.24.31.1800461
P932PMC publication ID6685101
P698PubMed publication ID31387672

P50authorJoan Puig-barberàQ42649355
Ainara Mira-IglesiasQ56862158
F X López-LabradorQ71257032
Miguel Tortajada-GirbésQ114340763
Germán Schwarz-ChavarriQ117281766
Mario Carballido-FernándezQ117281772
Víctor Baselga-MorenoQ117281773
Juan Mollar-MaseresQ117281776
Javier Diez-DomingoQ38641991
P2093author name stringOn Behalf Of The Valencia Hospital Network For The Study Of Influenza And Respiratory Viruses Disease
P2860cites workRepeated annual influenza vaccination and vaccine effectiveness: review of evidenceQ39340731
Repeated Vaccination Does Not Appear to Impact Upon Influenza Vaccine Effectiveness Against Hospitalization With Confirmed InfluenzaQ40280348
Effectiveness of influenza vaccination programme in preventing hospital admissions, Valencia, 2014/15 early results.Q41289359
MF59-adjuvanted and virosomal influenza vaccines for preventing influenza hospitalization in older people: comparative effectiveness using the Valencia health care information system.Q45109784
Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 seasonQ47135577
End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016/17.Q47154049
Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017.Q47159696
Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season.Q47413448
Evidence for Viral Interference and Cross-reactive Protective Immunity Between Influenza B Virus Lineages.Q47555103
Impact of seasonal influenza vaccination in the presence of vaccine interferenceQ47564122
Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018.Q49204982
Repeated influenza vaccination for preventing severe and fatal influenza infection in older adults: a multicentre case-control study.Q49400944
Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies.Q54261205
Typing (A/B) and subtyping (H1/H3/H5) of influenza A viruses by multiplex real-time RT-PCR assays.Q54526160
Dominant influenza A(H3N2) and B/Yamagata virus circulation in EU/EEA, 2016/17 and 2017/18 seasons, respectively.Q55224055
Influenza vaccine effectiveness in preventing hospitalisation of individuals 60 years of age and over with laboratory-confirmed influenza, Valencia Region, Spain, influenza season 2016/17.Q55339340
Recommended composition of influenza virus vaccines for use in the 2017–2018 northern hemisphere influenza seasonQ56763785
Rapid multiplex reverse transcription-PCR typing of influenza A and B virus, and subtyping of influenza A virus into H1, 2, 3, 5, 7, 9, N1 (human), N1 (animal), N2, and N7, including typing of novel swine origin influenza A (H1N1) virus, during the 2Q56977592
Vaccines against influenza WHO position paper – November 2012Q85607288
Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18Q87852509
Assessing Residual Bias in Estimating Influenza Vaccine Effectiveness: Comparison of High-dose Versus Standard-dose VaccinesQ93033985
Evolution and ecology of influenza A virusesQ24634698
New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0Q27860476
Pandemic versus epidemic influenza mortality: a pattern of changing age distributionQ28275622
Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010-2011 to 2014-2015.Q30151372
Impact of influenza vaccination on seasonal mortality in the US elderly population.Q30350187
Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case-control studyQ30394200
Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasonsQ34393525
Influenza vaccine effectiveness in preventing influenza A(H3N2)-related hospitalizations in adults targeted for vaccination by type of vaccine: a hospital-based test-negative study, 2011-2012 A(H3N2) predominant influenza season, Valencia, SpainQ34505958
Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic reviewQ34778408
Influenza B virus-specific CD8+ T-lymphocytes strongly cross-react with viruses of the opposing influenza B lineageQ36376605
The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary applicationQ36653410
Influenza B vaccine lineage selection--an optimized trivalent vaccineQ36690569
Indicators of socioeconomic position (part 2).Q36933672
The test-negative design for estimating influenza vaccine effectivenessQ38427246
Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza.Q38678530
Influenza Vaccine Effectiveness in Preventing Influenza Illness Among Children During School-based Outbreaks in the 2014-2015 Season in Beijing, ChinaQ39142665
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue31
P921main subjectinfluenza vaccineQ383260
periodic health examinationQ1762591
P577publication date2019-08-01
P1433published inEurosurveillanceQ14565070
P1476titleInfluenza vaccine effectiveness against laboratory-confirmed influenza in hospitalised adults aged 60 years or older, Valencia Region, Spain, 2017/18 influenza season
P478volume24

Reverse relations

Q89543170Vaccine effectiveness against influenza A(H3N2) and B among laboratory-confirmed, hospitalised older adults, Europe, 2017-18: A season of B lineage mismatched to the trivalent vaccinecites workP2860

Search more.